Thu, February 16, 2023
Wed, February 15, 2023
Tue, February 14, 2023

Andrew Fein Maintained (UBX) at Strong Buy and Held Target at $10 on, Feb 15th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-10-on-feb-15th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy and Held Target at $10 on, Feb 15th, 2023.

Andrew has made no other calls on UBX in the last 4 months.



There are 2 other peers that have a rating on UBX. Out of the 2 peers that are also analyzing UBX, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $12 on, Wednesday, November 16th, 2022
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $36 on, Wednesday, November 2nd, 2022

Publication Contributing Sources